FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

704262001: Siltuximab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3010576017 Siltuximab en Synonym Active Entire term case insensitive SNOMED CT core module
3010669017 Siltuximab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Siltuximab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Siltuximab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Siltuximab Inferred relationship Existential restriction modifier
Product containing siltuximab Has active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Siltuximab Inferred relationship Existential restriction modifier
Siltuximab Has active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing only siltuximab in parenteral dose form (medicinal product form) Has active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing siltuximab in parenteral dose form (medicinal product form) Has active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 400 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Siltuximab Inferred relationship Existential restriction modifier 1
Product containing precisely siltuximab 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Siltuximab Inferred relationship Existential restriction modifier 1
Siltuximab 100mg powder for solution for infusion vials Has active ingredient False Siltuximab Inferred relationship Existential restriction modifier
Siltuximab 400mg powder for solution for infusion vials Has active ingredient False Siltuximab Inferred relationship Existential restriction modifier
Siltuximab 400mg powder for solution for infusion vials Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier
Sylvant 400mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier
Sylvant 100mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier
Siltuximab 100mg powder for solution for infusion vials Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier
Siltuximab 100mg powder for solution for infusion vials 1 vial Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier
Siltuximab 400mg powder for solution for infusion vials 1 vial Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier
Sylvant 400mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) 1 vial Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier
Sylvant 100mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) 1 vial Has specific active ingredient True Siltuximab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start